A Tiny Biotech Just Posted 10× Stronger Cancer Results
Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.
Shutdown stalemate set to drag into sixth week as Trump pushes Republicans to change Senate rules
WASHINGTON (AP) — Republicans and Democrats remained at a stalemate on the over the weekend as it headed into its sixth week, with for millions of Americans and President Donald Trump pushing GOP leaders to change Senate rules to end it.
Obesity, diabetes treatments fuel Eli Lilly growth and spark bidding war
The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.
Gold Alert: Extraordinary Upside in One Stock (Not a Miner) - Ad
Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.
Social Security recipients get a 2.8% cost-of-living boost in 2026, average of $56 per month
WASHINGTON (AP) — The cost-of-living increase will go up by 2.8% in 2026, which translates to an average increase of more than $56 for retirees every month, agency officials said Friday.
Deep in Trump country, coal miners with black lung say government is suffocating the 'working man'
OAK HILL, W.Va. (AP) — Lisa Emery loves to talk about her “boys.” With each word, the respiratory therapist’s face softens and shines with pride. But keep her talking, and it doesn’t take long for that passion to switch to hurt. She knows the names, ages, families and the intimate stories of each one’s scarred lungs. She worries about a whole community of West Virginia coal miners — including a growing number in their 30s and 40s — who come to her for help while getting sicker and sicker from what used to be considered an old-timer’s disease: black lung.
Why Trump's "Smart Dollar" Could Rewrite the Rules - Ad
Congress just approved President Trump's latest plans for the dollar - and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.
Trump unveils deal to expand coverage and lower costs on obesity drugs
WASHINGTON (AP) — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.
FDA warns websites selling unapproved Botox for cosmetic purposes
Associated Press (AP) — U.S. health regulators on Wednesday sent warning letters to 18 websites selling and similar injectable drugs commonly used to smooth wrinkles.
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.
Analysts Lower Cigna Targets As PBM Segment Guidance Surprises Market
Cigna expects 2026–2027 margin pressure from its new rebate-free PBM model as major clients renew at lower margins, prompting analyst target cuts.
Pfizer COVID-19 vaccine sales tumble after government guidance on the shots narrows
The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them.
Is Big Pharma's Next Target Already in Play? - Ad
A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.
UniQure Shares Drop After FDA Shifts Stance On Huntington's Gene Therapy Data
UniQure shares fell after the FDA questioned the adequacy of data supporting its AMT-130 gene therapy for Huntington's disease, delaying BLA plans.
Kimberly-Clark Stock Plunges Over 16%, Kenvue Surges 20% In Monday Pre-Market: What's Going On?
Shares of Kimberly-Clark Corporation (NASDAQ: KMB) plunged 16.49% during the pre-market trading session on Monday, after it announced the acquisition of Kenvue Inc. (NYSE: KVUE).
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Pfizer sues to stop rival bid for drugmaker Metsera by Denmark's Novo Nordisk
Pfizer is suing over in its nearly $5 billion bid to buy the drugmaker Metsera.
Monkey escape in Mississippi gives a glimpse into the secretive world of animal research
The recent escape of several research monkeys after the truck carrying them is the latest glimpse into the secretive industry of animal research and the processes that allow key details of what happened to be kept from the public.
A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad
Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.
Federal health officials push effort to spur cheaper biotech drugs
Federal regulators are trying to make it easier to develop to powerful drugs that many Americans depend on to treat autoimmune diseases or cancers.
What to know as the annual sign-up window for health insurance arrives
Higher prices, less help and all hang over health insurance markets as shoppers start looking for coverage this week.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as January 29.
Trump administration moves to overrule state laws protecting credit reports from medical debt
NEW YORK (AP) — The Trump administration is moving to overrule any state laws that may protect consumers’ credit reports from medical debt and other debt issues.
Merck's New Cancer Therapy Combo Shows Significant Edge Over Rivals In Renal Cancer
Merck and Eisai report Phase 3 results showing Welireg plus Lenvima significantly improved progression-free survival in advanced kidney cancer.
Gold Bars Are Pouring, but This Miner is Still Priced Like a Startup - Ad
You'd expect a gold miner with production, a full refinery, and big-name investors to be trading at a premium. But this one? It's still under $1
Bill Gates calls for climate fight to shift focus from curbing emissions to reducing human suffering
NEW YORK (AP) — Bill Gates thinks climate change is a serious problem but it won't be the end of civilization. He thinks scientific innovation will curb it, and it’s instead time for a “strategic pivot” in the global climate fight: from focusing on limiting rising temperatures to fighting poverty and preventing disease.
UnitedHealth's Optum UK Draws Interest As Private Equity Firms Circle
Private equity firms, including Blackstone, are exploring bids for UnitedHealth's UK Optum unit just two years after the EMIS acquisition.
From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad
Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch.
Takeaways from AP's report on the growing dangers of heat on pregnant agriculture workers
Agricultural workers are already among the most vulnerable to extreme heat. For pregnant workers, because the body must work harder to cool down and requires more liquids, making it more easily dehydrated. While protections exist, experts say they need better enforcement and more are needed. The Associated Press interviewed four agricultural workers who recounted experiences of working in extreme heat while pregnant.
Health care compromise appears far off as the government shutdown stalemate persists
WASHINGTON (AP) — has reopened debate on what has been a central issue for both major political parties in the last 15 years: the future of .
Central Banks Are Buying More Gold Than Ever-And This U.S. Miner Is Ready to Oblige - Ad
Central banks are rapidly increasing their gold reserves-now nearly 20% of global assets. With rising demand and geopolitical pressure, U.S. gold supply is becoming more strategic than ever.
Most Americans are concerned about higher health care costs next year, an AP-NORC poll finds
WASHINGTON (AP) — Most U.S. adults are worried about health care becoming more expensive, according to a new AP-NORC poll, as they make and keeps in limbo for millions.
How Americans are feeling about their chances on the job market, according to an AP-NORC poll
WASHINGTON (AP) — Americans are growing increasingly concerned about their ability to find a good job under , an Associated Press-NORC Center for Public Affairs poll finds, in what is a potential warning sign for Republicans as a promised has given way to and .
Gold Alert: Extraordinary Upside in One Stock (Not a Miner) - Ad
Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.
Analyst See Noise In Q3 P&L, Affirms Abbott's Medtech Strength
Abbott eyes 10% EPS growth in 2026 with CGM momentum, new nutrition contracts, and medical device launches driving global expansion.
Johnson & Johnson Reports Strong Phase 3 Results For Multiple Myeloma Therapy
Tecvayli combined with Darzalex Faspro improves overall survival in relapsed/refractory multiple myeloma, Johnson & Johnson reports.
Why Trump's "Smart Dollar" Could Rewrite the Rules - Ad
Congress just approved President Trump's latest plans for the dollar - and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.
Johnson & Johnson Rules Out Big Acquisitions, Reiterates Focus On Small Deals: Analyst
Johnson & Johnson raised its 2025 revenue guidance as Stelara erosion slowed, while BofA maintained a Neutral rating citing fair valuation.
Broadway enters an anxious time as labor action threatens to roil theaters
NEW YORK (AP) — is a tense place these days after two major labor unions authorized strike action amid ongoing contract negotiations with producers.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.